Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.53
-0.6062-0.55%
Post-market: 110.50-0.0338-0.03%17:20 EDT
Volume:97.95K
Turnover:10.83M
Market Cap:1.00B
PE:89.56
High:111.04
Open:110.96
Low:110.01
Close:111.14
52wk High:118.00
52wk Low:85.91
Shares:9.09M
Float Shares:9.09M
Volume Ratio:0.41
T/O Rate:1.08%
Dividend:2.18
Dividend Rate:1.97%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):142.35

Loading ...

Dow Jones Top Company Headlines at 1 PM ET: Amazon Sued for Allegedly Discriminating Against Pregnant Workers | GE ...

Dow Jones
·
Sep 09

H.C. Wainwright reiterates Sell on Sarepta after Novartis study miss

TIPRANKS
·
Sep 09

Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon

MT Newswires Live
·
Sep 08

Dow Jones Top Company Headlines at 11 am ET: GE Aerospace to Buy Consolidated Precision Products | GameStop ...

Dow Jones
·
Sep 08

Novartis falls -12.9%

TIPRANKS
·
Sep 08

U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis

Reuters
·
Sep 08

Novartis's Failed Trial for Cholesterol Drug Leads to Broad Biopharma Selloff

Dow Jones
·
Sep 08

Novartis AG Stock (NVS) Opened Down by 12.63% on Sep 8: What Investors Need To Know

TradingKey
·
Sep 08

Novartis Down over 12%, on Pace for Record Percent Decrease

Dow Jones
·
Sep 08

Sector Update: Healthcare

MT Newswires Live
·
Sep 08

Novartis is Having a Very Bad September-and More Pain Could be on the Way

Dow Jones
·
Sep 08

Update: US Equity Futures Mostly Lower as Traders Assess Rising Oil, Canadian Retaliatory Tariffs

MT Newswires Live
·
Sep 08

【US Pre-Market】Middle East Energy Risks Escalate, Brent Crude Nears $100, Oil and Gas Stocks Rise; Novartis Plunges 13%

TradingKey
·
Sep 08

Monte Rosa Therapeutics to receive $50M milestone payment from Novartis

TIPRANKS
·
Sep 08

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 08

Beneath the Surface, the Next Market Leaders are Getting Ready to Break Out, Says Morgan Stanley

Dow Jones
·
Sep 08

Novartis Dealmaking Serves as Cautionary Tale for Pharma M&A

Dow Jones
·
Sep 08

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 08

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live
·
Sep 08

Swiss Pharma Giant Hit by Triple Trial Setbacks, Shares Plunge Nearly 10% in Steepest One-Day Drop Since 2020

Deep News
·
Sep 08